List of Vagifem drug patents

Vagifem is owned by Novo Nordisk Inc.

Vagifem contains Estradiol.

Vagifem has a total of 1 drug patent out of which 1 drug patent has expired.

Expired drug patents of Vagifem are:

  • US7018992

Vagifem was authorised for market use on 26 March, 1999.

Vagifem is available in tablet;vaginal dosage forms.

Vagifem can be used as treatment of atrophic vaginitis due to menopause.

The generics of Vagifem are possible to be released after 17 September, 2022.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7018992 NOVO NORDISK INC Hormone composition
Sep, 2022

(4 months ago)

Drugs and Companies using ESTRADIOL ingredient

Market Authorisation Date: 26 March, 1999

Treatment: Treatment of atrophic vaginitis due to menopause

Dosage: TABLET;VAGINAL

How can I launch a generic of VAGIFEM before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in